GlassScriptPhysician profile
Marisa I Rebeka
NPI 1588066013
$1,563.75
in general payments reported to CMS, 2019-2025
18 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.39 · 2022: $691 · 2023: $221 · 2024: $270 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.16 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $332.36 | 2022-2025 | Entyvio, Gattex |
| Abbvie INC. | $249.76 | 2021-2024 | |
| Madrigal Pharmaceuticals | $194.58 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.12 | 2022-2023 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $156.71 | 2024-2025 | Tremfya, Stelara |
| Gilead Sciences, INC. | $131.89 | 2022 | |
| Pfizer INC. | $70.80 | 2022-2024 | |
| Medtronic, INC. | $48.91 | 2023 | Pillcam |
| Genzyme Corporation | $37.89 | 2024 | |
| Aimmune Therapeutics, INC. | $37.14 | 2024 | |
| Nestle Healthcare Nutrition INC. | $24.56 | 2022 | |
| Ironwood Pharmaceuticals, INC | $22.22 | 2022 | |
| Daiichi Sankyo INC. | $20.50 | 2022 | |
| Novo Nordisk INC | $16.12 | 2023 | Ozempic, Rybelsus |
| Celgene Corporation | $15.62 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $15.60 | 2022 | |
| Lilly USA, LLC | $13.67 | 2022 | |
| Braintree Laboratories, INC. | $13.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Rebeka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.